Home/Filings/4/0001562180-22-001477
4//SEC Filing

Greene Barry E 4

Accession 0001562180-22-001477

CIK 0001597553other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:42 PM ET

Size

7.5 KB

Accession

0001562180-22-001477

Insider Transaction Report

Form 4
Period: 2022-02-11
Greene Barry E
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-11+69,92069,920 total
    Exercise: $43.04Exp: 2032-02-11Common Stock (69,920 underlying)
Footnotes (1)
  • [F1]The securities awarded on February 11, 2022 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 17,480 shares of common stock shall vest on the one year anniversary of February 11, 2022, with 52,440 shares vesting in 36 equal monthly installments thereafter.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:42 PM ET
Size
7.5 KB